• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病肾病患者中性粒细胞与淋巴细胞比值与全因死亡率和心血管死亡率的关系:一项基于美国国家健康与营养检查调查(NHANES)的前瞻性队列研究

Relationship of the Neutrophil-Lymphocyte Ratio with All-Cause and Cardiovascular Mortality in Patients with Diabetic Kidney Disease: A Prospective Cohort Study of NHANES Study.

作者信息

Zeng Guixing, Lin Yujie, Xie Peirui, Lin Jiarong, He Yaxing, Wei Junping

机构信息

Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China.

The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.

出版信息

J Multidiscip Healthc. 2024 May 21;17:2461-2473. doi: 10.2147/JMDH.S465317. eCollection 2024.

DOI:10.2147/JMDH.S465317
PMID:38799017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11127657/
Abstract

BACKGROUND

To investigate the association between the NLR and the risk of all-cause and cardiovascular mortality in US adults with diabetic kidney disease (DKD).

METHODS

The data utilized for this analysis were sourced from ten National Health and Nutrition Examination Survey cycles (1999-2018) with mortality data (up to 31 December 2019) via linkage to the National Death Index. The optimum NLR threshold for predicting survival outcomes was determined through the maximally selected rank statistics. Restricted cubic spline (RCS), weighted Cox proportional hazard regression, stratified analyses, and time-dependent receiver-operating characteristic curve (ROC) were employed to delineate the prospective correlations of the NLR with both all-cause and cardiovascular mortality.

RESULTS

In this investigation, a cohort comprising 2581 patients diagnosed with DKD was examined, encompassing 624 individuals with a higher NLR (≥3.07) and 1957 subjects with a lower NLR (<3.07). Over a median follow-up of 79 months (interquartile range, 44-128 months), 1103 deaths occurred, including 397 from cardiovascular causes and 706 from non-cardiovascular causes. The RCS analysis elucidated the positive linear correlation (both nonlinear > 0.05). In the multivariable analyses, each one-unit increase in the NLR value was correlated with a 51% increased risk of all-cause mortality (1.51(1.28, 1.77)) and a 71% increased risk of cardiovascular mortality (1.71(1.32, 2.21)). The results were largely consistent across stratified analyses encompassing variables such as age, sex, race/ethnicity, marital status, family income, education levels, BMI, drinking status, smoking status, hypertension, CVD, and anti-infective drugs ( for interaction >0.05 for all). Time-dependent ROC analyses underscored the NLR's credible predictive efficacy for both short-term and extended durations in forecasting both all-cause and cardiovascular mortality.

CONCLUSION

The findings emphasize the promising use of the NLR in stratifying and prognosticating the risk of mortality in DKD in clinical practice.

摘要

背景

研究美国糖尿病肾病(DKD)成人患者中性粒细胞与淋巴细胞比值(NLR)与全因死亡率和心血管死亡率风险之间的关联。

方法

本分析所使用的数据来自十个国家健康与营养检查调查周期(1999 - 2018年),通过与国家死亡指数链接获取死亡率数据(截至2019年12月31日)。通过最大选择秩统计确定预测生存结果的最佳NLR阈值。采用受限立方样条(RCS)、加权Cox比例风险回归、分层分析和时间依赖性受试者工作特征曲线(ROC)来描述NLR与全因死亡率和心血管死亡率之间的前瞻性相关性。

结果

在本次调查中,对一个由2581例诊断为DKD的患者组成的队列进行了检查,其中包括624例NLR较高(≥3.07)的个体和1957例NLR较低(<3.07)的个体。在中位随访79个月(四分位间距,44 - 128个月)期间,发生了1103例死亡,其中397例死于心血管原因,706例死于非心血管原因。RCS分析阐明了正线性相关性(两者非线性>0.05)。在多变量分析中,NLR值每增加一个单位,全因死亡率风险增加51%(1.51(1.28, 1.77)),心血管死亡率风险增加71%(1.71(1.32, 2.21))。在涵盖年龄、性别、种族/民族、婚姻状况、家庭收入、教育水平、体重指数、饮酒状况吸烟状况、高血压、心血管疾病和抗感染药物等变量的分层分析中,结果基本一致(所有交互作用>0.05)。时间依赖性ROC分析强调了NLR在预测全因死亡率和心血管死亡率的短期和长期方面具有可靠的预测效力。

结论

研究结果强调了NLR在临床实践中对DKD患者死亡风险进行分层和预后评估方面的潜在应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033c/11127657/16b1b15e6c0e/JMDH-17-2461-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033c/11127657/9c76cc087cdc/JMDH-17-2461-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033c/11127657/aab966dbd504/JMDH-17-2461-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033c/11127657/1ebf89aaa393/JMDH-17-2461-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033c/11127657/574cec16815f/JMDH-17-2461-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033c/11127657/df9598cc4ff9/JMDH-17-2461-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033c/11127657/16b1b15e6c0e/JMDH-17-2461-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033c/11127657/9c76cc087cdc/JMDH-17-2461-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033c/11127657/aab966dbd504/JMDH-17-2461-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033c/11127657/1ebf89aaa393/JMDH-17-2461-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033c/11127657/574cec16815f/JMDH-17-2461-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033c/11127657/df9598cc4ff9/JMDH-17-2461-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/033c/11127657/16b1b15e6c0e/JMDH-17-2461-g0006.jpg

相似文献

1
Relationship of the Neutrophil-Lymphocyte Ratio with All-Cause and Cardiovascular Mortality in Patients with Diabetic Kidney Disease: A Prospective Cohort Study of NHANES Study.糖尿病肾病患者中性粒细胞与淋巴细胞比值与全因死亡率和心血管死亡率的关系:一项基于美国国家健康与营养检查调查(NHANES)的前瞻性队列研究
J Multidiscip Healthc. 2024 May 21;17:2461-2473. doi: 10.2147/JMDH.S465317. eCollection 2024.
2
The neutrophil-lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: evidence from the NHANES 2003-2016.中性粒细胞与淋巴细胞比值作为糖尿病患者全因和心血管死亡率的危险因素:来自 NHANES 2003-2016 的证据。
Cardiovasc Diabetol. 2023 Sep 29;22(1):267. doi: 10.1186/s12933-023-01998-y.
3
Association of neutrophil-lymphocyte ratio with all-cause and cardiovascular mortality in US adults with diabetes and prediabetes: a prospective cohort study.中性粒细胞与淋巴细胞比值与美国糖尿病和糖尿病前期成人全因和心血管死亡率的关系:一项前瞻性队列研究。
BMC Endocr Disord. 2024 May 10;24(1):64. doi: 10.1186/s12902-024-01592-7.
4
Association of neutrophil-to-lymphocyte ratio and risk of cardiovascular and all-cause mortality in hypertension patients.高血压患者中性粒细胞与淋巴细胞比值与心血管及全因死亡率风险的关联
Heliyon. 2024 Mar 7;10(6):e27517. doi: 10.1016/j.heliyon.2024.e27517. eCollection 2024 Mar 30.
5
Neutrophil-to-lymphocyte ratio as a predictor of all-cause and cardiovascular mortality in coronary heart disease and hypertensive patients: a retrospective cohort study.中性粒细胞与淋巴细胞比值对冠心病和高血压患者全因及心血管死亡率的预测作用:一项回顾性队列研究。
Front Endocrinol (Lausanne). 2024 Aug 21;15:1442165. doi: 10.3389/fendo.2024.1442165. eCollection 2024.
6
The neutrophil-lymphocyte ratio predicts all-cause and cardiovascular mortality among United States adults with COPD: results from NHANES 1999-2018.中性粒细胞与淋巴细胞比值可预测美国慢性阻塞性肺疾病(COPD)成人患者的全因死亡率和心血管死亡率:1999 - 2018年美国国家健康与营养检查调查(NHANES)结果
Front Med (Lausanne). 2024 Sep 25;11:1443749. doi: 10.3389/fmed.2024.1443749. eCollection 2024.
7
The neutrophil-to-lymphocyte ratio is associated with all-cause and cardiovascular mortality among individuals with hypertension.中性粒细胞与淋巴细胞比值与高血压患者的全因死亡率和心血管死亡率相关。
Cardiovasc Diabetol. 2024 Apr 2;23(1):117. doi: 10.1186/s12933-024-02191-5.
8
Association between monocyte-lymphocyte ratio and all-cause and cardiovascular mortality in patients with chronic kidney diseases: A data analysis from national health and nutrition examination survey (NHANES) 2003-2010.单核细胞-淋巴细胞比值与慢性肾脏病患者全因和心血管死亡率的关系:来自 2003-2010 年全国健康和营养调查(NHANES)的数据分析。
Ren Fail. 2024 Dec;46(1):2352126. doi: 10.1080/0886022X.2024.2352126. Epub 2024 Jun 4.
9
The neutrophil-lymphocyte ratio predicts all-cause and cardiovascular mortality among U.S. adults with rheumatoid arthritis: results from NHANES 1999-2020.中性粒细胞与淋巴细胞比值可预测美国类风湿关节炎患者的全因和心血管死亡率:来自 NHANES 1999-2020 的结果。
Front Immunol. 2023 Nov 17;14:1309835. doi: 10.3389/fimmu.2023.1309835. eCollection 2023.
10
Association between neutrophil-to-lymphocyte ratio and short-term all-cause mortality in patients with cerebrovascular disease admitted to the intensive care unit-a study based on the MIMIC-IV database.重症监护病房收治的脑血管疾病患者中性粒细胞与淋巴细胞比值与短期全因死亡率的关联——一项基于MIMIC-IV数据库的研究
Front Med (Lausanne). 2024 Oct 2;11:1457364. doi: 10.3389/fmed.2024.1457364. eCollection 2024.

引用本文的文献

1
Association of immune-inflammation indexes with incidence and prognosis of diabetic nephropathy: a systematic review and meta-analysis.免疫炎症指标与糖尿病肾病发病率及预后的关联:一项系统评价与Meta分析
Front Endocrinol (Lausanne). 2025 Aug 18;16:1532682. doi: 10.3389/fendo.2025.1532682. eCollection 2025.
2
Prognostic effect of neutrophil percentage-to-albumin ratio (NPAR) on all-cause and cardiovascular mortality in diabetic kidney disease (DKD): NHANES 1999-2018.中性粒细胞百分比与白蛋白比值(NPAR)对糖尿病肾病(DKD)全因死亡率和心血管死亡率的预后影响:1999 - 2018年美国国家健康与营养检查调查(NHANES)
Diabetol Metab Syndr. 2025 Mar 28;17(1):105. doi: 10.1186/s13098-025-01674-z.
3

本文引用的文献

1
The neutrophil-lymphocyte ratio predicts all-cause and cardiovascular mortality among U.S. adults with rheumatoid arthritis: results from NHANES 1999-2020.中性粒细胞与淋巴细胞比值可预测美国类风湿关节炎患者的全因和心血管死亡率:来自 NHANES 1999-2020 的结果。
Front Immunol. 2023 Nov 17;14:1309835. doi: 10.3389/fimmu.2023.1309835. eCollection 2023.
2
Dapagliflozin alleviates renal inflammation and protects against diabetic kidney diseases, both dependent and independent of blood glucose levels.达格列净可减轻肾脏炎症,并可预防糖尿病肾病,无论血糖水平是否依赖。
Front Immunol. 2023 Nov 9;14:1205834. doi: 10.3389/fimmu.2023.1205834. eCollection 2023.
3
Association of neutrophil-to-lymphocyte ratio with all-cause and cardiovascular mortality in CVD patients with diabetes or pre-diabetes.
中性粒细胞与淋巴细胞比值与合并糖尿病或糖尿病前期的心血管疾病患者全因及心血管死亡率的相关性。
Sci Rep. 2024 Oct 17;14(1):24324. doi: 10.1038/s41598-024-74642-8.
Role of neutrophil-lymphocyte ratio as a prognostic marker for type 2 diabetic nephropathy among Indians.
中性粒细胞与淋巴细胞比值作为印度人2型糖尿病肾病预后标志物的作用。
Bioinformation. 2023 Apr 30;19(4):375-379. doi: 10.6026/97320630019375. eCollection 2023.
4
The neutrophil-lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: evidence from the NHANES 2003-2016.中性粒细胞与淋巴细胞比值作为糖尿病患者全因和心血管死亡率的危险因素:来自 NHANES 2003-2016 的证据。
Cardiovasc Diabetol. 2023 Sep 29;22(1):267. doi: 10.1186/s12933-023-01998-y.
5
Meta-Inflammation and New Anti-Diabetic Drugs: A New Chance to Knock Down Residual Cardiovascular Risk.代谢性炎症与新型抗糖尿病药物:降低残余心血管风险的新契机。
Int J Mol Sci. 2023 May 12;24(10):8643. doi: 10.3390/ijms24108643.
6
Association of urine and plasma ADMA with atherosclerotic risk in DKD cardiovascular disease risk in diabetic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.尿和血浆 ADMA 与糖尿病肾病心血管疾病风险中的动脉粥样硬化风险的关联:来自慢性肾功能不全队列(CRIC)研究的结果。
Nephrol Dial Transplant. 2023 Nov 30;38(12):2809-2815. doi: 10.1093/ndt/gfad103.
7
Relationship between Serial Serum Neutrophil-Lymphocyte Ratio, Cardiovascular Mortality, and All-Cause Mortality in Chinese Peritoneal Dialysis Patients.中国腹膜透析患者中性粒细胞与淋巴细胞比值与心血管死亡率和全因死亡率的关系。
Kidney Blood Press Res. 2023;48(1):414-423. doi: 10.1159/000530554. Epub 2023 Apr 25.
8
The Preoperative Neutrophil-Lymphocyte Ratio Is an Independent Predictive Factor in Predicting 1-Year Mortality in Amputated Diabetic Foot Patients.
J Foot Ankle Surg. 2023 Sep-Oct;62(5):816-819. doi: 10.1053/j.jfas.2023.04.007. Epub 2023 Apr 24.
9
n-3 PUFA poor seafood consumption is associated with higher risk of gout, whereas n-3 PUFA rich seafood is not: NHANES 2007-2016.2007 - 2016年美国国家健康与营养检查调查显示,食用富含n - 3多不饱和脂肪酸(PUFA)的海鲜可降低痛风风险,而食用富含n - 3多不饱和脂肪酸(PUFA)的海鲜则无此关联。
Front Nutr. 2023 Apr 4;10:1075877. doi: 10.3389/fnut.2023.1075877. eCollection 2023.
10
Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: Post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials.中性粒细胞与淋巴细胞比值可预测2型糖尿病患者的心血管事件:SUSTAIN 6和PIONEER 6心血管结局试验的事后分析
Diabetes Obes Metab. 2023 Aug;25(8):2398-2401. doi: 10.1111/dom.15088. Epub 2023 May 8.